Cited by 61Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal Infections and Studies

Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India

Open access
Chander, Jagdish, Singla, Nidhi, Sidhu, Shailpreet Kaur, Gombar, Satinder·2013·The Journal of Infection in Developing Countries

Abstract

INTRODUCTION: Bloodstream infections due to Candida species are becoming a major cause of morbidity and mortality in hospitalized patients. The spectrum of candidemia has changed with the emergence of non-albicans Candida species, especially among critically ill patients. METHODOLOGY: In a retrospective study (July 2009 to December 2009) on candidemia, various Candida species isolated from blood cultures were characterized and studied along with the determination of their antifungal susceptibility to amphotericin B, itraconazole, and fluconazole by Etest. Probable risk factors for patients in the intensive care unit (ICU) presenting with candidemia were also analyzed. RESULTS: During the study period, a total of 4651 samples were received, out of which 468 samples (10.06%) were positive for growth of organisms: 441 (94.20%) aerobic bacterial pathogens and 27 (5.79%) Candida species. The most common Candida spp. isolate was C. tropicalis (40.8%) followed by C. albicans (29.6%), C. glabrata (18.5%) and others (11.1%). Out of the 27 Candida strains, 24 (88.9%) were isolated from patients treated in the ICU. Among these, association of previous use of broad-spectrum antibiotics in 22 patients (91.6%) and central line catheter insertion in 20 patients (83.3%) were found to be statistically significant as compared to non-candidemia patients (p <0.05). Antifungal susceptibility testing of the isolates revealed a lower level of drug resistance to amphotericin B (18.5% of the isolates) versus 77.8% resistance to fluconazole. CONCLUSION: Rapid changes in the rate of infection, potential risk factors, and emergence of non-albicans Candida demand continued surveillance of this serious bloodstream fungal infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3855/jidc.2623

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Eickhoff TC (1992) Antibiotics and nosocomial infections. In: Bennet JV, Branchman PS, editors. Hospital Infections, 3 rd edition. Boston: Little, Brown and Company 245-264.

Cited by

Sorted by citations

Authors
Chander, J., Singla, N., Sidhu, S. K., & Gombar, S.
Affiliations
Government Medical College and Hospital (IN)
Venue
The Journal of Infection in Developing Countries
Published
2013-09-16
Volume
7
Issue
09
Pages
670-675
ISSN
1972-2680 (ISSN-L)
OpenAlex
W2158275536
Cited by
61
References
22
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 8 · 2016: 3 · 2015: 8 · 2014: 6
FWCI
4.12
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • The Journal of Infection in Developing Countries (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
candidemia, Candida species, fungemia, non-albicans Candida, Candida tropicalis, Candida albicans, Candida glabrata, antifungal susceptibility, fluconazole resistance, amphotericin B resistance, intensive care unit, risk factors, broad-spectrum antibiotic use, central venous catheters, critically ill patients
MeSH terms
Aged, Aged, 80 and over, Amphotericin B, Antifungal Agents, Candida, Humans, India, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Risk Factors, Fluconazole, Prevalence, Itraconazole, Drug Resistance, Fungal, Candidemia, Tertiary Care Centers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review